Daniel J. Abdun-Nabi
2016
In 2016, Daniel J. Abdun-Nabi earned a total compensation of $3.2M as President and Chief Executive Officer at Emergent BioSolutions, a 13% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $456,588 |
|---|---|
| Option Awards | $743,183 |
| Salary | $776,629 |
| Stock Awards | $1,199,984 |
| Other | $8,683 |
| Total | $3,185,067 |
Abdun-Nabi received $1.2M in stock awards, accounting for 38% of the total pay in 2016.
Abdun-Nabi also received $456.6K in non-equity incentive plan, $743.2K in option awards, $776.6K in salary and $8.7K in other compensation.
Rankings
In 2016, Daniel J. Abdun-Nabi's compensation ranked 2,966th out of 14,075 executives tracked by ExecPay. In other words, Abdun-Nabi earned more than 78.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,966 out of 14,075 | 79th |
Division Manufacturing | 1,029 out of 5,486 | 81st |
Major group Chemicals And Allied Products | 303 out of 1,900 | 84th |
Industry group Drugs | 220 out of 1,543 | 86th |
Industry Pharmaceutical Preparations | 170 out of 1,173 | 86th |
Source: SEC filing on April 13, 2017.
Abdun-Nabi's colleagues
We found four more compensation records of executives who worked with Daniel J. Abdun-Nabi at Emergent BioSolutions in 2016.